- Report
- March 2026
- 140 Pages
Global
From €4554EUR$4,850USD£3,799GBP
- Report
- February 2026
- 134 Pages
Global
From €4554EUR$4,850USD£3,799GBP
- Report
- August 2026
- 106 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- January 2026
- 105 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- September 2026
- 120 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- July 2026
- 120 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- March 2026
- 160 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- March 2026
- 194 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- August 2026
- 109 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- August 2026
- 105 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- March 2026
- 126 Pages
Global
From €3500EUR$3,993USD£3,022GBP
- Report
- November 2026
Global
From €3746EUR$3,990USD£3,125GBP
- Report
- March 2026
- 203 Pages
Global
From €4554EUR$4,850USD£3,799GBP
- Report
- February 2026
- 188 Pages
Global
From €4554EUR$4,850USD£3,799GBP
- Report
- February 2026
- 189 Pages
Global
From €4554EUR$4,850USD£3,799GBP
- Report
- January 2026
- 164 Pages
Global
From €4554EUR$4,850USD£3,799GBP
- Report
- December 2025
- 150 Pages
Global
From €4554EUR$4,850USD£3,799GBP
- Report
- September 2026
- 52 Pages
Global
From €7042EUR$7,500USD£5,875GBP
- Report
- June 2026
Global
From €7042EUR$7,500USD£5,875GBP
- Training
- November 2027
- 2 Days
Global
€1612EUR$1,776USD£1,299GBP
€1860EUR$2,050USD£1,499GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more